Oligodendrogliomas Not Yet Recruiting Phase 2 / 3 Trials for Temozolomide (DB00853)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Not Yet Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04105374Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed GlioblastomaTreatment